Pyrimido[6′,1′:2,3]imidazo[4,5-b][1,6]naphthyridine compounds as CK2 inhibitors

hawafiz kfu icon
book cover

Pyrimido[6′,1′:2,3]imidazo[4,5-b][1,6]naphthyridine compounds as CK2 inhibitors

  • US 12,129,254 B1

  • الصحة - Health

  • 2024

  • مكتب البراءات الأمريكي - US Patent Office

  • Tratrat; Christophe (Al-Ahsa, SA), Haroun; Michelyne (Al-Ahsa, SA)

  • Novel pyrimido[6′,1′:2,3]imidazo[4,5-b][1,6]naphthyridine compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The pyrimido[6′,1′:2,3]imidazo[4,5-b][1,6]naphthyridine compounds, identified as CK2 inhibitors, are useful as anticancer and/or antitumor agents, and as agents for treating other kinase-associated conditions including inflammation, pain, and certain immunological disorders, and other types of diseases such as diabetes, viral infection, neurodegenerative diseases.